- Home
- ESPR vs CAN Comparison
ESPR vs CAN Comparison
Compare ESPR & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CAN
- Stock Information
- Founded
- ESPR 2008
- CAN 2013
- Country
- ESPR United States
- CAN Singapore
- Employees
- ESPR N/A
- CAN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CAN Semiconductors
- Sector
- ESPR Health Care
- CAN Technology
- Exchange
- ESPR Nasdaq
- CAN Nasdaq
- Market Cap
- ESPR 319.2M
- CAN 359.7M
- IPO Year
- ESPR 2013
- CAN 2019
- Fundamental
- Price
- ESPR $2.33
- CAN $1.32
- Analyst Decision
- ESPR Buy
- CAN Strong Buy
- Analyst Count
- ESPR 4
- CAN 4
- Target Price
- ESPR $8.17
- CAN $3.38
- AVG Volume (30 Days)
- ESPR 3.4M
- CAN 7.2M
- Earning Date
- ESPR 11-07-2024
- CAN 11-26-2024
- Dividend Yield
- ESPR N/A
- CAN N/A
- EPS Growth
- ESPR N/A
- CAN N/A
- EPS
- ESPR N/A
- CAN N/A
- Revenue
- ESPR $295,451,000.00
- CAN $189,341,000.00
- Revenue This Year
- ESPR $199.60
- CAN $23.62
- Revenue Next Year
- ESPR $19.36
- CAN $58.80
- P/E Ratio
- ESPR N/A
- CAN N/A
- Revenue Growth
- ESPR 187.12
- CAN N/A
- 52 Week Low
- ESPR $0.87
- CAN $0.72
- 52 Week High
- ESPR $3.40
- CAN $3.50
- Technical
- Relative Strength Index (RSI)
- ESPR 54.58
- CAN 62.91
- Support Level
- ESPR $2.05
- CAN $1.14
- Resistance Level
- ESPR $2.25
- CAN $1.49
- Average True Range (ATR)
- ESPR 0.12
- CAN 0.12
- MACD
- ESPR -0.00
- CAN 0.04
- Stochastic Oscillator
- ESPR 61.54
- CAN 82.83
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.